Bufetolol Hydrochloride

盐酸布非洛尔

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBufetolol Hydrochloride
Drug Alias NameAdobiolY-6124
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonists
TargetsBeta adrenergic receptors
Therapy Area/IndicationsAngina PectorisTachycardia, Sinus
Global Approved IndicationsAngina PectorisTachycardia, Sinus
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date1974/01/12
Country/TerritoryJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Tanabe Pharma Corp
China Registration ClassN/A

Develop Information

Active CompaniesMitsubishi Tanabe Pharma
Inactive CompaniesN/A
Active IndicationsAngina PectorisTachycardia, Sinus
Inactive IndicationsN/A

Other Information

ATC CodeC07AB
Related LinksWikipediaKEGG